A consecutive series of 36 children with bleeding from oesophageal varices secondary to extrahepatic portal hypertension was successfully treated by endoscopic injection sclerotherapy and followed up over a mean period of 8-7 years after variceal obliteration. There were no deaths from portal hypertension or its treatment and morbidity related to Summary oflongterm outcome after endoscopic injection sclerotherapy.
Bleeding from oesophageal varices is the commonest cause of serious gastrointestinal haemorrhage in children and is associated with a death rate of 5-9% in those with portal vein obstruction and a considerably greater morbidity and mortality in children with cirrhosis.' Opinions on the primary management of this condition have long been divided between those who advocate portosystemic shunting2 and those who favour endoscopic injection sclerotherapy.6°The published results of endoscopic injection sclerotherapy in large numbers of children with oesophageal varices have recently encouraged the widespread acceptance of the technique'0"'3 but there is little information on the longterm results. While this may be less important for those with primary intrahepatic disease, in whom prognosis is largely determined by underlying liver pathology, such data are essential for those with portal vein obstruction in whom variceal bleeding is the main threat to life.
We therefore reviewed a cohort of children who had previously had injection sclerotherapy for bleeding oesophageal varices secondary to extrahepatic portal hypertension. 
